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OBJECTIVES We sought to evaluate the relation of segmental tissue Doppler (TD) velocities to both the
regional amount of interstitial fibrosis and the myocyte beta-adrenergic receptor density in
humans.
BACKGROUND The systolic myocardial velocity (Sm) and early diastolic myocardial velocity (Em) acquired
by TD are promising new indexes of left ventricular function. However, their structural and
functional correlates in humans are still unknown.
METHODS Ten patients with coronary artery disease underwent echocardiographic examination includ-
ing TD imaging, along with transmural endomyocardial biopsy at the time of coronary bypass
surgery (two biopsies per patient for a total of 20 specimens). The specimens were analyzed
for percent interstitial fibrosis and beta-adrenergic receptor density.
RESULTS Normal segments (n 5 8) had a higher beta-adrenoceptor density (2,280 6 738 vs. 1,373 6
460, p 5 0.03) and a lower amount of interstitial fibrosis (13 6 3.3% vs. 28 6 11.5%, p 5
0.002) than dysfunctional segments (n 5 12). Myocardial systolic velocity and Em were also
significantly higher (9.5 6 2.7 vs. 5.9 6 1.8 cm/s, p 5 0.025 and 11.3 6 2.8 vs. 6.4 6
2.1 cm/s, p 5 0.002, respectively) in normal segments. A significant relationship was present
between Em and the beta-adrenergic receptor density (r 5 0.78, p , 0.001) and percent
interstitial fibrosis (r 5 20.7, p 5 0.0026), which together accounted for 81% of the variance
observed in Em. Likewise, a significant relationship was present between Sm and the
beta-adrenergic receptor density (r 5 0.68, p , 0.001) and the percent interstitial fibrosis (r 5
20.66, p 5 0.004) and together accounted for 62% of the variance observed in Sm.
CONCLUSIONS Systolic myocardial velocity and Em are strongly dependent on both the number of myocytes
and the myocardial beta-adrenergic receptor density. (J Am Coll Cardiol 2000;36:891–6) ©
2000 by the American College of Cardiology
The tissue Doppler (TD) derived myocardial systolic veloc-
ity (Sm) and early diastolic velocity (Em) are novel indexes
of left ventricular systolic and diastolic performance that can
provide important information on both global and regional
systolic and diastolic function (1–10). They have also been
applied clinically in the diagnosis of coronary artery disease
(CAD) in conjunction with stress echocardiography (11).
However, to date there are no studies in humans relating
these velocities to myocardial structure and the determi-
nants of cardiac contraction and relaxation at the cellular
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level; such information would validate the utility of these
velocities as indexes of myocardial function.
Regional function is dependent on the number of normally
functioning myocytes and is reduced with myocyte necrosis
and replacement fibrosis. It is also dependent on the adrenergic
nervous system and the circulating catecholamines, which play
an important role in regulating the myocardial inotropic and
lusitropic states at rest and with exercise. Recently, alterations
in myocyte beta-adrenergic receptor density were described in
diseases associated with myocardial dysfunction (12,13). Spe-
cifically, myocardial beta-adrenergic receptor density and cyclic
AMP are reduced in chronic heart failure contributing to the
decrease in myocardial contractility and the impaired relaxation
noted in patients with this disease. Alternatively, transgenic
mice overexpressing the beta-2-adrenergic receptors exhibit
enhanced cardiac function (14). Our objective, therefore, was
to evaluate the relation of segmental TD velocities to the
regional amount of interstitial fibrosis and the myocyte beta-
adrenergic receptor density in patients who had known CAD
and left ventricular regional dysfunction who were scheduled to
undergo coronary artery bypass surgery.
METHODS
Ten consecutive patients with stable CAD and regional left
ventricular dysfunction in the distribution of one or more
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coronary arteries ($70% diameter stenosis), already sched-
uled for coronary artery bypass surgery, were prospectively
enrolled in this investigation. The protocol was approved by
the Baylor College of Medicine Affiliated Hospitals Insti-
tutional Review Board, and all subjects provided written
informed consent before participation.
Two to five days before surgery, patients underwent a
two-dimensional and TD echocardiographic examination.
At surgery and before cardioplegia, transmural myocardial
biopsies were obtained from the core of the myocardial
segments of interest. Areas of interest were determined a
priori as segments with normal or depressed function from
transthoracic studies performed before surgery (see below
for details). Transesophageal echocardiography (TEE) was
utilized to direct the biopsy to the selected segments. These
were the same segments in which the TD myocardial
velocities were measured. Biopsies were performed with a
20 mm, 14 gauge Tru-Cut biopsy needle. In each patient,
two biopsies were acquired. In eight patients, one biopsy
was acquired from a normal segment (to serve as control)
and another from a dysfunctional segment. However, two
patients lacked a normal segment, and biopsies were ac-
quired from two distinct, dysfunctional segments. We
defined normal segments as ones meeting all the following
criteria: an end-diastolic thickness $0.9 cm, normal base-
line function and a normal contractile reserve (augmented
contractility in response to dobutamine without functional
deterioration at higher doses) (11). The middle segments of
the anterior and lateral walls were biopsied in each patient.
The lateral wall was most frequently the normal wall and,
thus, served to provide the control segment. In two subjects
the sample obtained was only sufficient to analyze the
beta-adrenoreceptor density.
Echocardiographic studies and analysis. Presurgery im-
ages were obtained with either an Acuson (Sequoia, Moun-
tain View, California) or a Hewlett-Packard (Sonos 5500,
Andover, Massachusetts) ultrasound system equipped with
the TD program. A complete echocardiographic study was
performed using standard views. The TD program was
applied in the pulse wave mode, and a 5 mm sample volume
was placed in the center of each myocardial segment of
interest identified by color-coded TD in the apical views.
Gains and filters were adjusted as needed to eliminate
background noise and allow for a clear tissue signal. Tissue
Doppler velocities (range set from 230 to 30 cm/s) were
recorded for 5 to 10 cardiac cycles at a sweep speed of
100 mm/s and stored on videotape for later analysis. The
position of the pulse wave Doppler sample volume was
always in the midsegments of the anterior (A2), lateral (L2),
posterior (P2) and inferior (I2) walls. Regional TD derived
velocities were analyzed by a single observer blinded to the
pathology data using a computerized station (Digisonics
500, Houston, Texas) to determine Sm, Em and late
diastolic velocities (Am) (Fig. 1, bottom panel) (intraob-
server variability 8 6 3%). Myocardial systolic velocity was
measured .50 ms from onset of the QRS complex to
exclude velocity shifts occurring during isovolumic contrac-
tion (6,7,11).
Pathological analysis. Visualization and quantification of
beta receptors. All pathological analysis was performed by
experienced pathologists who were blinded to all other data.
Fresh biopsy samples of cardiac tissue were embedded in
media containing 10.24% polyvinyl alcohol, 4.2% polyeth-
Abbreviations and Acronyms
Am 5 late diastolic velocity
CAD 5 coronary artery disease
Em 5 early diastolic velocity
Sm 5 myocardial systolic velocity
TD 5 tissue Doppler
TEE 5 transesophageal echocardiography
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Figure 1. (Top panel) Fluorescent labeling of beta-adrenoreceptors
(green) and nuclei (blue with 4*6*-diamidino-2-phenylindole chloride,
0.1 g/ml). (A) Normal segment (B) Dysfunctional segment. (Middle
panel) Mallory’s trichrome stain for interstitial fibrosis. (A) Normal
segment; (B) Dysfunctional segment. (Lower panel) Tissue Doppler
velocities. Am 5 late diastolic myocardial velocity; Em 5 early diastolic
myocardial velocity; Sm 5 systolic myocardial velocity; from normal (A)
and dysfunctional (B) segments. Notice the higher beta-adrenergic recep-
tor density, the lower amount of interstitial fibrosis and the preserved Sm
and Em velocities in the normal segment.
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ylene glycol and 85.5% sucrose (O.C.T. Compound Tissue-
Tek, Torrance, California) and placed on dry ice to freeze.
The blocks were housed at 4°C in a Reichert Histo STAT
chryotome and sectioned with a diamond knife at a thick-
ness of 10 6 3 mm. Sections were attached to 18 mm
circular glass coverslips coated with Poly-L-Lysine (Sigma)
and placed in 3.7% paraformaldehyde for 5 min at room
temperature.
Tissue slices were visualized using an Applied Precision
DeltaVision Scanning Fluorescence Microscope (Issaquah,
Washington) fitted with an Olympus IX70 microscope and
deconvolution capabilities. The probe used was a green
fluorescent BODIPY FL labeled analogue of the beta-
adrenergic receptor agonist CGP 12177 (Molecular Probes,
Eugene, Oregon) (15,16). The sections were stained with
the fluorescent receptor probe for 30 min at 37°C and placed
on a glass slide on one drop of ethanol. Samples were
visualized at a slice thickness of 0.25 mm, with the appro-
priate number of slices being acquired to pass from bottom
to top of the tissue. After acquisition, the image was
subjected to deconvolution (five iterations), then stacked
and volume rendered with Imaris software (Bitplane AG,
Zurich, Switzerland).
The tissue samples were also stained with anti-actin
antibodies, and secondary antibodies were tagged with an
appropriate probe, as well as 4969-diamidino-2-
phenylindole chloride, 0.1 g/ml for visualization of nuclei.
So as to not interfere with the excitation/emission windows
of individual probes (Molecular Probes), a combination of
tags was used. Stereology employed counting of distinct
areas of fluorescence in three separate tissue slices after
deconvolution and image enhancement (nine magnified
fields in total). This methodology allowed delineation of
individual receptors for counting (Fig. 1, top panel). Mean
values for receptor density were determined per 60 mm 3
60 mm tissue slices.
Cell type recognition. The sections were composed of three
types of cells: fibroblasts, endothelial cells and myocytes. To
determine the cell types, a combination of probes was used:
4969-diamidino-2-phenylindole chloride, 0.1 g/ml (Molec-
ular Probes) to identify nuclei and a secondary antibody
(goat antirabbit or goat antimouse) tagged with either
BODIPY or Texas Red to probe smooth muscle actin.
Actin and myosin were identified with a BODIPY tagged
secondary antibody (goat antirabbit). Smooth muscle actin
identified vascular endothelial cells, while actin and myosin
patterns and lack of intercalated discs were used to differ-
entiate between myocytes and fibroblasts.
Assessment of fibrosis. To determine the extent of fibrosis,
after the specimens were fixed in 10% buffered formalin,
processed through a series of ethanol solutions, embedded
in paraffin and cut into 3 mm sections, they were stained
with hematoxylin-eosin and Mallory’s trichrome stain. Fi-
brosis stains purple with trichrome, which distinguishes it
from viable myocardium, which stains pink (Fig. 1, middle
panel). Fibrosis was quantitated with a computer image
analysis technique using Optima Bioscan software and
expressed as a percentage of the total biopsied section (17).
Statistics. Data are presented as mean 6 SD. Two tailed
unpaired t testing was applied to compare beta-adrenergic
receptor density, percent interstitial fibrosis and TD veloc-
ities between normal and abnormal segments. Linear re-
gression analysis was used to correlate TD velocities with
beta-adrenergic receptor density and percent interstitial
fibrosis. Significance was set at a p value #0.05.
RESULTS
The study group had a mean age of 61 6 7 years (range: 54
to 70, five women) and a mean ejection fraction of 32 6
10% (range: 20% to 45%). All except two patients had
angina, and 8/10 had hypertension. The mean New York
Heart Association class was 1.6 6 0.9 (range: 1 to 3). Five
patients had three-vessel disease; three had two-vessel
disease (one patient with left anterior descending and
circumflex disease; the other two, circumflex and right
coronary disease), and two had single vessel disease involv-
ing the proximal segment of the left anterior descending
coronary artery. All patients were on nitrates; one patient
was receiving beta-blockers, and three were on calcium
channel blockers.
Relation of TD velocities to beta-adrenergic receptor
density and interstitial fibrosis. The beta-adrenergic re-
ceptors were located predominantly in the myocardium and
not in the interstitial space. A weak, inverse and nonsignif-
icant correlation was present between the beta-adrenergic
receptor density and the percent of interstitial fibrosis (r 5
20.3, R2 5 0.1, p 5 0.12). Receptor density ranged from
704 to 3,200 and averaged 1,648 6 705 per 60 mm 3
60 mm tissue slices. The percent interstitial fibrosis ranged
between 7% and 53%. Normal segments (n 5 8), when
compared with dysfunctional (n 5 12) segments, exhibited
a significantly higher beta-adrenergic receptor density
(2,280 6 738 vs. 1,373 6 460, p 5 0.03) and a significantly
lower percent of interstitial fibrosis (13 6 3.3% vs. 28 6
11.5%, p 5 0.002). Tissue Doppler velocities were satisfac-
torily recorded from all biopsied segments. In comparison
with the 12 dysfunctional segments, the 8 normal segments
had higher TD velocities (Sm normals: 9.5 6 2.7 vs. 5.9 6
1.8 cm/s for dysfunctional segments, p 5 0.025; Em
normals: 11.3 6 2.8 vs. 6.4 6 2.1 cm/s for dysfunctional
segments, p 5 0.002; Am normals: 13.5 6 6 vs. 8.2 6
2.5 cm/s for abnormal segments, p 5 0.1).
In the 20 segments combined, a significant relation was
present between the beta-adrenergic receptor density and
segmental Em velocity (r 5 0.78, R2 5 0.59, p , 0.001,
Fig. 2), with a significant relation also noted between Em
and the percent of interstitial fibrosis (r 5 20.7, R2 5 0.49,
p 5 0.0026, Fig. 2). On multiple regression analysis, the
beta-adrenergic receptor density and the percent of inter-
stitial fibrosis accounted for 81% of the variance observed in
Em (r 5 0.9, R2 5 0.81, p , 0.001). Even within the eight
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normal segments, Em still related significantly to both
beta-adrenoceptor density (r 5 0.79, p 5 0.007) and the
percent interstitial fibrosis (r 5 20.75, p 5 0.03). Likewise,
Em related to these two variables on analyzing the 12
abnormal segments alone (beta-adrenoceptor density: r 5
0.75, p 5 0.01; percent interstitial fibrosis: r 5 20.64, p 5
0.08).
Regarding Sm, significant relations were present with the
percent of interstitial fibrosis (r 5 20.66, R2 5 0.44, p 5
0.004, Fig. 3) and beta-adrenoceptor density (r 5 0.68,
R2 5 0.46, p , 0.001, Fig. 3). On multiple regression
analysis, beta-adrenergic receptor density and percent of
interstitial fibrosis accounted for 62% of the variance ob-
served in Sm (r 5 0.79, R2 5 0.62, p 5 0.001). Similar to
the findings with Em velocity, Sm showed inverse relations
with percent interstitial fibrosis in normal (n 5 8, r 5
20.62, p 5 0.16) and dysfunctional segments (n 5 12, r 5
20.8, p 5 0.05). Myocardial systolic velocity also showed a
positive relation with beta-adrenoceptor density in dysfunc-
tional (r 5 0.75, p 5 0.05) and normal segments (r 5 0.59,
p 5 0.2). Overall, Am had only a weak insignificant relation
with the percent of interstitial fibrosis (r 5 20.43, p 5
0.126).
Myocardial systolic velocity (7.9 6 4 to 9.5 6 5, n 5 20,
p , 0.05) and Em (8.8 6 4.5 to 10.8 6 4.7, n 5 20, p ,
0.05) both significantly increased with low dose dobut-
amine, whereas Am (11 6 5.9 to 9.9 6 5.7, n 5 20, p 5
0.4) did not. A significant relation was also present when
Sm and Em changes with low dose dobutamine were related
to interstitial fibrosis (r 5 20.72, 20.68, respectively, both
p , 0.04) and beta-adrenergic receptor density (r 5 0.74,
0.73, respectively, both p , 0.03).
DISCUSSION
We have shown for the first time that Em and Sm are
strongly dependent on both the percent of interstitial
fibrosis and the myocardial beta-adrenergic receptor density.
It is interesting that even on analyzing the abnormal (or
normal) segments alone, Sm and Em related to the percent
of interstitial fibrosis and beta-adrenoceptor density. We
believe that the weak insignificant relation of fibrosis with
beta-adrenoceptor density and the incremental predictive
value of both parameters on multiple regression analysis are
further proof that the decline in beta receptor density in
abnormal segments is not merely due to replacement of
myocytes by fibrous tissue but is the result of the decrease in
the number of beta receptors per myocyte.
In our patient cohort, as the amount of interstitial fibrosis
increased, Sm and Em decreased. Because myocyte contrac-
tion determines the regional systolic function, it is not
surprising that we found an inverse relation between the
Figure 2. (Upper panel) Relation of Em to beta-adrenoreceptor density.
(Lower panel) Relation of Em to the percent of interstitial fibrosis. Em 5
early diastolic velocity.
Figure 3. (Upper panel) Relation of Sm to beta-adrenoreceptor density.
(Lower panel) Relation of Sm to the percent of interstitial fibrosis. Sm 5
myocardial systolic velocity.
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extent of regional interstitial fibrosis and segmental Sm.
Likewise, the finding of a negative relation between inter-
stitial fibrosis and Em supports the ventricular myocytes
contribution to regional Em velocity. This helps explain the
abnormal early diastolic wall motion of dysfunctional seg-
ments in patients with CAD and myocardial infarction.
Such abnormal segments frequently exhibit reduced out-
ward motion in early diastole and may actually move
inwards during filling, a finding that has been applied to
diagnose CAD with reasonable accuracy (18).
It is generally accepted that in the human heart beta-
adrenergic receptors coupled with adenylate cyclase mediate
positive inotropic effects on isolated ventricular muscle
preparations (19). Furthermore, the downregulation of car-
diac beta-adrenergic receptors in heart failure may signifi-
cantly contribute to the impaired contractility frequently
present in these patients (13,20). Therefore, in our investi-
gation, cardiac segments with a higher beta-adrenergic
receptor density had better contractility as manifested by the
Sm velocity.
Regarding Em velocity, our study shows that this novel
parameter of myocardial relaxation is dependent on recep-
tors that influence the left ventricular lusitropic state. There
is ample evidence that beta-adrenoceptors help myocardial
relaxation in humans. Parker et al. (21) reported that
beta-adrenergic receptor stimulation in patients with heart
failure results in a significant acceleration of isovolumic
relaxation even to an extent comparable with that in normal
individuals. This has been shown to occur through cAMP-
dependent phosphorylation of phospholamban and tropo-
nin I (22). Phospholamban phosphorylation results in an
increase in Ca ATPase activity that pumps Ca into the
sarcoplasmic reticulum, thus decreasing the amount of
calcium at the contractile proteins. Phosphorylation of
troponin I also aids relaxation as it desensitizes the contrac-
tile proteins to calcium.
Interestingly, Am had no significant relation with the
beta-adrenergic receptor density. This finding is in contrast
with the strong relation of the receptor density to the other
velocities. These observations support the active ventricular
myocardium contribution to Sm and Em and suggest that
Am is perhaps reflective of passive ventricular motion or
maybe more dependent on atrial myocardium function.
However, the latter hypothesis remains to be examined.
Study limitations. One biopsy was obtained per dysfunc-
tional segment. However, it is our belief that these speci-
mens reflect well the core tissue in the biopsied segments
since we used TEE to guide these core biopsies. Although
more specimens could have been obtained, this was greatly
limited by patient safety. The relation between TD veloci-
ties and histopathology data were not perfect with some
degree of scatter. This may have been related to some
contribution of heart translocation to the actual velocities.
Therefore, the correlations could have been improved had
we examined Em and Sm gradients. However, TD veloci-
ties were recorded from the apical views, where transloca-
tion is expected to have a minimal impact on Sm and Em.
Also, TD velocities were not acquired by TEE at the time
of surgery. This was done to minimize the contribution of
heart translocation, which is typically more prominent after
sternotomy. Alternatively, it is possible that other variables
like regional energy stores, cytokine levels and contractile
proteins, which determine regional function and were not
evaluated in our study, accounted for some degree of the
scatter.
Conclusions. In summary, this investigation provides
novel information on the structural and functional correlates
of Sm and Em velocities that further support their use as
indexes of myocardial function.
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